Accepted 5 January 1999 Carpenter, J. M. (1999). What do we know about chrysidoid (Hymenoptera) relationships?. Ð Zoologica Scripta 28, 215±231. The phylogeny of the superfamily Chrysidoidea is reviewed. Relationships among the families proposed by Carpenter (1986) were confirmed by Brothers and Carpenter (1993). The status of knowledge of phylogenetic relationships within families is assessed....

nanoparticles classified in 4 overall groups containing: metallic nanoparticles, ceramic nanoparticles, polymeric nanoparticles and semiconductor nanoparticles. these nanoparticles are used in some biomedical applications such as carrying medicine and photographing agents. with attention to different criteria which are both qualitative and quantitative, selecting the most suitable nanoparticles...

The increased obstetrical risk associated with diabetes first recognized in pregnancy, i.e., gestational diabetes, was first described in the postwar period by Dr. J. P. Hoet in a paper written in French and translated into English by Dr. F.D.W. Lukens for publication in Diabetes in 1954 (1). Not long after that the National Institutes of Health developed a program in the epidemiology of chroni...

Carpenter syndrome (Acrocephalopolysyndactyly type 2, OMIM 201000) is a rarely seen autosomal recessive disorder. In addition to abnormalities such as acrocephaly, craniosynostosis, facial asymmetry, polydactyly and syndactyly, obesity, hypogonadism, mental retardation, and corneal opacity, it may frequently be accompanied by congenital heart diseases such as ventricular septal defect, patent d...

Rationale: Left bundle branch block is a diagnostic utility for ST-segment elevation myocardial infarction equivalent. Consequently, administration of thrombolytic pivotal step. Emergent Sgarbosa criteria and their modification are considered helpful guide keys. Wavy triple an electrocardiographic sign (Yasser Sign) novel in hypocalcemia. Interestingly, the presentation COVID-19 pneumonia with ...

recent data have begun to elucidate the genetic architecture of schizophrenia, as well as provide new insights into the relationships of specific genetic factors across diagnostic boundaries, with specific symptom domains, and in the prediction of antipsychotic treatment response. not surprisingly, work conducted at the Maryland psychiatric research center (Mprc), led by dr William carpenter, h...

Recent data have begun to elucidate the genetic architecture of schizophrenia, as well as provide new insights into the relationships of specific genetic factors across diagnostic boundaries, with specific symptom domains, and in the prediction of antipsychotic treatment response. Not surprisingly, work conducted at the Maryland Psychiatric Research Center (MPRC), led by Dr William Carpenter, h...